Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

Curr Urol Rep. 2021 Jan 7;22(1):5. doi: 10.1007/s11934-020-01017-7.

Abstract

Purpose of review: To review the efficacy and safety of mirabegron in men with overactive bladder (OAB) and benign prostatic hyperplasia (BPH).

Recent findings: Numerous studies have shown mirabegron to be efficacious and safe in treating symptoms of OAB. More recent studies evaluating the use of mirabegron in men with OAB and BPH have also shown the medication to be effective with few adverse side effects when used as monotherapy or in combination therapy. Mirabegron is an effective and safe treatment for men with OAB and BPH.

Keywords: Lower urinary tract symptoms; Mirabegron; Overactive; Prostatic hyperplasia; Urinary bladder.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Acetanilides / therapeutic use*
  • Adrenergic beta-3 Receptor Agonists / therapeutic use*
  • Aged
  • Humans
  • Lower Urinary Tract Symptoms / drug therapy*
  • Lower Urinary Tract Symptoms / etiology
  • Male
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / drug therapy*
  • Randomized Controlled Trials as Topic
  • Thiazoles / therapeutic use*
  • Treatment Outcome
  • Urinary Bladder, Overactive / complications
  • Urinary Bladder, Overactive / drug therapy*
  • Urological Agents / therapeutic use*

Substances

  • Acetanilides
  • Adrenergic beta-3 Receptor Agonists
  • Thiazoles
  • Urological Agents
  • mirabegron